{"nct_id":"NCT00848029","title":"Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules","status":"COMPLETED","status_verified_date":"2011-12","start_date":"2008-11","start_date_type":null,"primary_completion_date":"2009-06","primary_completion_date_type":"ACTUAL","completion_date":"2009-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}